DexCom, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $718.5M | $573.3M | $402.0M | $259.2M | $160.0M | $99.9M | $76.3M | $48.6M |
| Cost of Revenue | $226.4M | $194.9M | $123.6M | $82.9M | $59.9M | $53.3M | $40.4M | $30.2M |
| Gross Profit | $492.1M | $378.4M | $278.4M | $176.3M | $100.1M | $46.6M | $35.9M | $18.4M |
| Gross Margin | 68.5% | 66.0% | 69.3% | 68.0% | 62.6% | 46.6% | 47.1% | 37.9% |
| Operating Expenses | ||||||||
| Research & Development | $185.4M | $156.1M | $137.5M | $69.4M | $44.8M | $38.3M | $29.6M | $23.2M |
| SG&A Expense | $349.2M | $286.2M | $198.0M | $128.4M | $84.2M | $64.0M | $51.1M | $40.5M |
| Operating Income | $-42.5M | $-63.9M | $-57.1M | $-21.5M | $-28.9M | $-55.7M | $-44.8M | $-45.3M |
| Operating Margin | -5.9% | -11.1% | -14.2% | -8.3% | -18.1% | -55.8% | -58.7% | -93.2% |
| Interest Expense | $12.8M | $700.0K | $400.0K | $800.0K | $900.0K | $200.0K | $0 | $1.5M |
| Pretax Income | $-48.6M | $-64.9M | $-57.5M | $-22.3M | $-29.8M | $-55.8M | $-44.7M | $-55.2M |
| Income Tax Expense | $1.6M | $700.0K | $100.0K | $100.0K | $0 | $-1.3M | $0 | $0 |
| Net Income | $-50.2M | $-65.6M | $-57.6M | $-22.4M | $-29.8M | $-54.5M | $-44.7M | $-55.2M |
| Net Margin | -7.0% | -11.4% | -14.3% | -8.6% | -18.6% | -54.6% | -58.6% | -113.6% |
| EPS (Basic) | $-0.12 | $-0.16 | $-0.14 | $-0.06 | $-0.08 | $-0.16 | $-0.14 | $-0.19 |
| EPS (Diluted) | $-0.12 | $-0.16 | $-0.14 | $-0.06 | $-0.08 | $-0.16 | $-0.14 | $-0.19 |
| Shares Outstanding (Basic) | 431.5M | 423.0M | 408.5M | 386.5M | 362.5M | 347.5M | 337.5M | 310.4M |
| Shares Outstanding (Diluted) | 431.5M | 423.0M | 408.5M | 386.5M | 362.5M | 347.5M | 337.5M | 310.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |